RT Book, Section
A1 Bissonnette, Bruno
A1 Luginbuehl, Igor
A1 Engelhardt, Thomas
SR Print(0)
ID 1164079202
T1 Morgagni-Stewart-Morel Syndrome
T2 Syndromes: Rapid Recognition and Perioperative Implications, 2e
YR 2019
FD 2019
PB McGraw-Hill Education
PP New York, NY
SN 9781259861789
LK accessanesthesiology.mhmedical.com/content.aspx?aid=1164079202
RD 2024/04/25
AB It  is  a  polyglandular  endocrine  syndrome  characterized  by  diabetes  insipidus,  mellitus,  and  hyperparathyroidism.  Clinically,  affected  individual  present  with  the  classic  triad  of  (a)  hyperostosis  frontalis  interna,  (b)  adipositas,  and  (c)  virilism  and  hirsutism.  There  is  a  peculiar,  noninflammatory,  usually  benign  osteopathy  with  symmetrical  thickening  of  the  frontal,  parietal,  or  occipital  bones  as  a  result  of  deposits  on  the  internal  aspects  of  the  squama  frontalis.  Other  clinical  features  include  menstrual  disorders,  galactorrhea,  mental  dysfunctions,  fatigue,  somnolence,  visual  disorders,  vertigo,  tinnitus,  obesity,  polyphagia,  polydipsia,  polyuria,  loss  of  sense  of  smell,  decreased  glucose  tolerance,  seizures,  and  involvement  of  the  second,  fifth,  and  seventh  cranial  nerves  with  hemiplegia  and  hemiparesis.